Article

Roche Chairman to Step Down in 2014

Franz B. Humer, chairman of the board of directors of the Roche Group, will not stand for re-election to the Board in 2014.

Franz B. Humer, chairman of the board of directors of the Roche Group, announced at the company’s March 5 annual general meeting that he will not stand for re-election to the Board in 2014. The company will nominate a successor for the chairmanship in autumn 2013.

The Roche Board has decided that Humer’s successor will also serve as non-executive Chairman, thus maintaining the established separation of the offices of Chairman and Chief Executive Officer, according to a company statement.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx